RxDoctor Payments Data

Jameson Mattingly, MD

Otology & Neurotology · Knoxville, TNNPI 1255697975

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,837 of the $3,585 with a category attached, or 79.1%. 21 manufacturers reported payments, led by Med-el Corporation at 38.4% of the total. Reporting peaked in 2024 at $1,788 and has fallen 62.9% since, to $664 in 2025.

$3,585in general payments, 2019–2025

Across 88 payments — averaging $40.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$1K
  • Regeneron Healthcare Solutions, Inc.$353
  • Cochlear Americas$316
  • Sanofi$261
  • Grace Medical, Inc.$233
  • Advanced Bionics, LLC$195
  • plus $851 from 15 others

What the payments were for

  • Travel & lodging$74821%
  • Food & beverage$2,83779%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$231,020
Medicare patients
590
Services billed
1,636

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin204$5,362
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth24$2,790
Ipratropium Bromide73$2,085
Fluticasone Propionate71$1,201
Azelastine Hcl28$800
Cephalexin109$656
Nortriptyline Hcl63$543
Doxycycline Hyclate28$329
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim39$268
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid30$258
Topiramate38$256
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$252
Ondansetron Hcl68$243
Prednisone81$232
Oxycodone Hcl131$207

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →